Takeda Oncology Invests in Talent, Pipeline Growth Despite Turbulent Market

In spite of a tumultuous economy, many life science companies have started the year off strong, expanding their pipelines and aiding organizations with fewer resources through partnerships.

In a recent report published by BDO, 43% of life sciences CFOs surveyed stated they plan to pursue a collaboration agreement to bring in cash in 2023.